Ezetimibe works in the gut and can't cross the blood-brain barrier — but its metabolite, ezetimibe glucuronide, can. Animal studies show it interferes with hexokinase and reduces brain protein glycosylation, producing anti-inflammatory effects. Neurologists already report anecdotal cognitive benefits in patients.